CLINICAL_TRIALS
trial_result
· 2017-09-20
Clinical Trial Update: Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07 [Phase 2]
Summary
Phase 2 long-term extension safety study for patients with dementia of the Alzheimer's type who completed CPC-001-07.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | Conditions: Dementia of the Alzheimer's Type | Phase 2 | Status: COMPLETED